Nanomedicines enhance minimally invasive therapy of pancreatic cancer

Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy

“…18 Within the realms of combinatorial approaches to cancer therapy, several nanoplatforms are being developed for anticancer therapies to enhance their selectivity and efficacy. 19 Nanotechnology offers new therapeutic and diagnostic methods with high efficacy and fewer adverse effects compared to conventional therapies. 20 Various types of nanoparticles have been developed for cancer therapy, such as liposomes, solid-lipid nanoparticles, polymeric nanoparticles, extracellular vesicles, gold nanoparticles, quantum dots, and magnetic nanoparticles 21 (Fig.…”

Sugar-based drug-free systemic immunoregulating and imageable nanoparticles promote the efficacy of immune checkpoint inhibitors in aggressive cancer

“…The treatment of glioblastoma (GBM) and pancreatic cancer (PC) remains a formidable challenge due to drug delivery issues and suppressed immune responses 1,2 . To address these challenges, numerous researchers are currently focused on developing a versatile therapeutic nanoparticle (NP) that can be applied to several treatment modalities at a speci c treatment time interval, such as phototherapy or drug delivery [3][4][5][6][7] . NP uptake relies on phagocytosis and speci c transporters, and the effects of NPs are shaped by their speci c formulation, which includes their molecular payloads 8 .…”